Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.870
-0.055 (-1.88%)
Apr 28, 2026, 2:50 PM CET
Atrys Health Revenue
In the year 2025, Atrys Health had annual revenue of 144.31M EUR with 7.00% growth. Atrys Health had revenue of 26.81M in the half year ending December 31, 2025, a decrease of -73.65%.
Revenue
144.31M
Revenue Growth
+7.00%
P/S Ratio
1.54
Revenue / Employee
219.99K
Employees
1,985
Market Cap
222.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 144.31M | 9.44M | 7.00% |
| Dec 31, 2024 | 134.88M | -71.23M | -34.56% |
| Dec 31, 2023 | 206.10M | 42.90M | 26.28% |
| Dec 31, 2022 | 163.20M | 39.35M | 31.77% |
| Dec 31, 2021 | 123.85M | 90.04M | 266.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.11B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 251.89M |
| Pharma Mar | 221.39M |
| Labiana Health | 71.67M |